LSTM's Dr. Jennifer Lord is first author on a paper looking at the impact of climate change on the vectors of sleeping sickness in Africa.
Oct 23, 2018
0
0
LSTM's Dr. Adam Roberts is a co-author on a new paper published in Nature Communications which reports conserved collateral susceptibility to antibiotics in the human pathogen Escherichia coli.
Sep 10, 2018
0
44
In one-fifth of people with active tuberculosis (TB), the site of disease is outside the lungs (extrapulmonary TB). Some forms of extrapulmonary TB, such as TB meningitis, are extremely dangerous, where a rapid diagnosis ...
Aug 28, 2018
0
0
In a viral haemorrhagic disease where up to 40% of people developing it die, it is remarkable that doctors still do not agree whether the only recognised treatment, an antiviral drug called ribavirin, makes a difference. ...
Jun 5, 2018
1
1
LSTM's Dr. Maxine Caws is co-lead investigator on an advanced genetics study published in Nature Genetics, which has shown that a virulent strain of tuberculosis (TB) has adapted to transmit among young adults in Ho Chi Minh ...
May 22, 2018
0
46
Researchers from LSTM, with partners from a number of international institutions, have shown the rapid selection of a novel P450 enzyme leading to insecticide resistance in a major malaria vector.
Apr 20, 2018
0
13
LSTM's Dr. Gabriela Gomes is senior author on a new study which outlines the importance of using variation in mosquito susceptibility as a parameter in mathematical modelling to realistically assess the impact of Wolbachia ...
Apr 19, 2018
0
1
Researchers from the Liverpool School of Tropical Medicine (LSTM) have shown the large potential impact of a completely new type of antimalarial drug that kills mosquitoes, as opposed to existing drugs that target the parasite, ...
Mar 28, 2018
0
33
New research published today in The Lancet Infectious Diseases, suggests the effectiveness of large-scale distribution of medication (known as Mass Drug Administration or MDA) to treat lymphatic filariasis (LF) in urban areas ...
Feb 5, 2018
0
2
A single dose of primaquine is thought to stop people with P. falciparum malaria infecting mosquitoes, which could help bring down malaria transmission. In this Cochrane Review update prepared by an international team of ...
Feb 2, 2018
0
1
